/Investor DB

Portland Seed Fund — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Biomotumbiomotum.cominMar 2022

Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke.

HealthtechMedical DevicesRoboticsPortland, US

Ray Browning(CEO & Co Founder)inZach Lerner(CTO & Co Founder)in

Co-investorsBronco VenturesCreative Destruction Lab (CDL)Elevate Capital

mpathicmpathic.aiin𝕏Jun 2022

Mpathic provides red-teaming and model safety evaluation services for conversational AI systems, using a curated network of over 5,000 licensed U.S.-based clinical experts including psychologists, psychiatrists, and social workers to surface harms, test for bias and misinformation, and design evaluation frameworks.

AI & Machine LearningCybersecurityDigital HealthEnterprise SoftwareMental Health

Grin Lord(Founder)in

Co-investorsFirst Row PartnersGraham Walker VentureIdeashipIlluminate VenturesNext Frontier CapitalVerissimo Ventures+2 more

Overwatchoverwatchdata.aiin𝕏Apr 2022 · $11M

Overwatch Data provides an AI-powered threat intelligence platform that monitors digital sources to detect and combat fraud and security risks for enterprise security and risk teams.

AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareNew York City, US

Arjun Bisen(Founder)inZara Perumal(Founder)inTad Mielnicki

Co-investorsA*Frontline VenturesGravity VenturesNew Era Capital PartnersPathlight VenturesPruVen Capital Partners+8 more

Overwatch Imagingoverwatchimaging.cominApr 2022 · $11M

Overwatch Imaging develops sensor autonomy software and smart sensors for airborne intelligence missions, delivering real-time imagery processing and automated detection capabilities for government and commercial customers worldwide.

AI & Machine LearningDefense TechGovTechHardwareHood River, US

Greg Davis(Founder & CEO)in

Co-investorsElevate CapitalShield CapitalSQUADRA VENTURES

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.